Healthcare Data Monetization Market Size, Share & Trends

Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies), Region - Global Forecast to 2028

Report Code: HIT 8682 Jun, 2023, by marketsandmarkets.com

Updated on : September 24, 2024

Overview of the Healthcare Data Monetization Market

Healthcare data monetization market forecasted to transform from $0.4 billion in 2023 to USD $0.9 billion by 2028, driven by a CAGR of 18.5%. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of EHR adoption primarily drives the market growth, the increase in use of external data sources, the need to curtail escalating healthcare costs, increasing partnerships and collaborations among players, and growing investments in advanced analytics. Additionally, factors such rising adoption of AI in precision medicine, and the explosion in bioinformatics data and large healthcare datasets are also contributing to the market growth.

Healthcare Data Monetization Market

To know about the assumptions considered for the study, Request for Free Sample Report

Healthcare Data Monetization Market

Healthcare Data Monetization Market Dynamics

Driver: Increase in use of external data sources

External data sources refer to data collected from sources outside of a healthcare organization, such as social media, wearables, consumer data brokers, and other sources. By incorporating external data sources into their analytics and insights, healthcare organizations can gain a more comprehensive view of patient health and behavior, which can lead to improved outcomes and new revenue streams.

One example of the increasing use of external data sources is the integration of data from wearables and other digital devices into healthcare analytics platforms. Wearables such as fitness trackers and smartwatches can collect a wide range of patient health and behavior data, including activity levels, heart rate, and sleep patterns. By integrating this data into healthcare analytics platforms, healthcare organizations can gain a more comprehensive view of patient health and behavior, which can lead to improved outcomes and new revenue streams. The global IoT medical devices market is expected to grow at a CAGR of 28.9% from 2021 to 2026. While according to a research study, the number of active IoT devices is expected to grow to ~31 billion by 2025. As healthcare organizations look to gain a more comprehensive view of patient health and behavior and create new revenue streams through data-driven insights, the rapidly increasing demand for wearables and medical IoT devices is expected to offer several opportunities to market players.

Restraint: Regulatory constraints to impact the growth of the market during the forecast period

Regulatory constraints are a significant challenge impacting healthcare data monetization growth. Healthcare data is subject to various laws and regulations governing data privacy, security, and use, making it challenging for organizations to collect, store, and use data for commercial purposes.

One of the primary regulations impacting healthcare data monetization is the Health Insurance Portability and Accountability Act (HIPAA). HIPAA is a federal law that sets national standards for protecting the privacy and security of protected health information (PHI). PHI includes any information that can be used to identify an individual's health status or healthcare services. Covered entities, such as healthcare providers and health plans, are required to comply with HIPAA regulations to protect the privacy and security of PHI. This can include obtaining patient consent before using or disclosing their data, implementing technical and administrative safeguards to protect data, and reporting data breaches.

HIPAA regulations can be a barrier to healthcare data monetization as organizations must comply with strict requirements to use and disclose PHI. For example, a healthcare provider looking to sell patient data to a pharmaceutical company for research must ensure that they have obtained patient consent and implemented appropriate safeguards to protect the data. Failure to comply with HIPAA regulations can result in significant fines and penalties.

Opportunity: Rising Demand for Real-World Evidence

The rising demand for real-world evidence (RWE) presents a significant market opportunity for healthcare data monetization. Real-world evidence refers to data collected from real-world patient populations in everyday clinical practice, outside the controlled environment of clinical trials. This type of data provides valuable insights into treatment outcomes, safety profiles, comparative effectiveness, and patient experiences, which are essential for evidence-based decision-making in healthcare. Healthcare organizations that possess extensive and high-quality RWE datasets can monetize this data by collaborating with various stakeholders in the healthcare ecosystem.

Challenge: Security concerns

Increased use of automated technologies such as EHRs, medical claims processing, and the move towards healthcare integration and health information exchanges (HIEs) have helped expand healthcare privacy and security landscape. Electronic exchange of patient data offers greater reach and efficiency in healthcare delivery but has high-security risks due to the broader access offered.

Approximately one-third of data breaches result in medical identity theft in the healthcare industry, mainly due to the lack of internal control over patient information, outdated policies, and procedures or non-adherence to existing ones, and inadequate personnel training. The HIPAA Journal recorded 712 healthcare data breaches in its 2021 breach list in the US, an increase of 10.9% over the total number of breaches tracked in 2020. Between 2009 and 2021, 4,419 healthcare data breaches of 500 or more records have been reported to the HHS Office for Civil Rights. Those breaches have resulted in the loss, theft, exposure, or impermissible disclosure of 314,063,186 healthcare records. That equates to more than 94.63% of the 2021 population of the US. In 2018, healthcare data breaches of 500 or more records were reported at around 1 per day. The rate has only doubled in the four years since. In 2021, an average of 1.95 healthcare data breaches of 500 or more records were reported daily. Thus, creating a secure communication platform is a significant challenge faced by IT vendors catering to the healthcare industry. Potential security concerns related to HCIT systems may lead to a rise in the sense of insecurity among users and, hence, restrain their adoption until secure healthcare data monetization solutions are available in the market.

Healthcare Data Monetization Market Ecosystem

Well-known, financially secure producers of data monetization systems and platforms are prominent players in this market. These companies have been in operation for a while and have a broad range of products, cutting-edge technologies, and robust international sales and marketing networks. Key companies in this market include Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), and others.

Healthcare Data Monetization Market Ecosystem

Direct data monetization is expected to acquire the largest size of healthcare data monetization market, by type

Based on type, the market is segmented into direct data monetization and indirect data monetization. The direct data monetization segment is expected to dominate the market in 2023. Direct data monetization is becoming popular in healthcare due to the need for efficient data management, interoperability, cost reduction, and improved patient outcomes. It allows healthcare providers to access data from multiple sources in real-time, standardize data formats, reduce infrastructure costs, and make informed decisions about patient care by identifying trends and patterns in patient data.

Based on deployment, on-premise segment is anticipated to dominate the healthcare data monetization market in 2023

Based on deployment, the market is segmented into on-premise and cloud. On-premise segment is expected to dominate the market in 2023. On-premise models offer multivendor architecture, which lowers the risk of data breaches and external attacks. Buyers mainly opt for these delivery models due to the security benefits associated with them. These factors are driving the growth of the on-premise deployment model segment.

Based on the end user, pharmaceutical & biotechnology companies segment of the healthcare data monetization market is expected to register the highest CAGR during the forecast period

Based on the end user, the market is broadly segmented into pharmaceutical & biotechnology companies, healthcare payers, healthcare providers, medical technology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to register the highest CAGR during the forecast period. The pharma and biotech companies segment includes pharma and biotech companies, and contract research and manufacturing organizations. Pharmaceutical companies are one of the key stakeholders in the healthcare ecosystem and are likely to benefit the most from comprehensive health data. The data serves to inform decision making, influence the direction of research efforts, as well as provide information on the potential expansion of certain medications. For instance. Data that is linked in any way to health behavior, such as medication usage patterns, is also a hot commodity for many pharmaceuticals. Hence, this segment represents a key source to fund the collection/procurement of health data that they will then utilize for their operations. Pharma companies often able to use that data or resell it for large profits to other interested entities.

Healthcare Data Monetization Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America is expected to account for the largest share in healthcare data monetization market in 2023

The global market has been segmented based on region: North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. In 2023, North America is expected to account for the largest market share followed by Europe. The large share of North America in the global healthcare analytics market can be attributed to the implementation of federal health mandates that encourage the adoption of HCIT solutions, an increasing focus on population health management, a significant amount of VC investments, growing pressure to reduce healthcare costs, technological advancements, and high product & service availability in this region. Moreover, most of the leading players in the healthcare analytics market have their headquarters in North America.

The healthcare data monetization market is dominated by a few globally established players such as Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), among others.

Healthcare Data Monetization Market Report Scope

Report Metric

Details

Market Revenue in 2023

$0.4 billion

Projected Revenue by 2028

$0.9 billion

Revenue Rate

Poised to grow at a CAGR of 18.5%

Market Driver

Increase in use of external data sources

Market Opportunity

Rising Demand for Real-World Evidence

This report categorizes the global healthcare data monetization market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Direct Data Monetization
    • Software
    • Services
  • Indirect Data Monetization
    • Software
    • Services

By Deployment

  • On-premise
  • Cloud

By End User

  • Pharmaceutical & Biotechnology Companies
  • Healthcare Providers
  • Healthcare Payers
  • Medical Technology Companies
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • RoAPAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In October 2022, Oracle Corporation introduced a planning solution for the healthcare industry as part of its Fusion Cloud Enterprise Performance Management (EPM) offering. The solution aims to help healthcare organizations improve financial performance and patient care by enabling them to model scenarios, optimize resources, and make better finance, workforce, and patient care decisions.
  • In April 2023, Microsoft Corporation and Epic Systems expanded their collaboration to integrate generative AI into healthcare by combining Azure OpenAI Service with Epic's electronic health record (EHR) software. The collaboration aimed to enhance patient care, increase productivity, and improve financial integrity in health systems globally.
  • In February 2023, Redox and Google Cloud partnered to simplify the exchange of healthcare data, enabling better and faster decision-making for healthcare organizations. Redox's platform would be replicated on Google Cloud, offering customers access to Redox's products and services.
  • In April 2023, Salesforce announced new Customer 360 for Health capabilities aimed at enhancing personalized patient experiences and reducing operational costs for healthcare providers. These innovations leverage real-time data, AI, and automation to address the challenges faced by healthcare organizations in meeting customer expectations.
  • In May 2023, HTEC Group joined the SAS IoT Partner Ecosystem to partner on delivering innovative solutions in industries such as healthcare, life sciences, logistics, and more. The partnership aimed to develop joint offerings that enable global enterprise companies to apply cutting-edge data-driven, IoT, edge, and cloud-enabled solutions to their business challenges.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

INTRODUCTION
24
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
48
PREMIUM INSIGHTS
51
MARKET OVERVIEW
55
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing use of external data sources
    - Increasing adoption of electronic health records (EHRs)
    - Growing volume of large and complex healthcare datasets
    - Rising need to curtail escalating healthcare costs
    RESTRAINTS
    - Lack of data standardization and interoperability
    - Regulatory constraints
    OPPORTUNITIES
    - Rising demand for real-world evidence
    - Emergence of personalized medicine and genomics
    CHALLENGES
    - Security concerns
INDUSTRY TRENDS
68
  • 6.1 INTRODUCTION
  • 6.2 TYPES OF HEALTHCARE DATA MONETIZATION SOLUTIONS
    DIRECT DATA MONETIZATION
    INDIRECT DATA MONETIZATION
  • 6.3 TECHNOLOGY ANALYSIS
    DATA AS A SERVICE
    INSIGHT AS A SERVICE
    ANALYTICS-ENABLED PLATFORM AS A SERVICE
    EMBEDDED ANALYTICS
  • 6.4 TARIFF AND REGULATORY LANDSCAPE
    REGULATIONS
    - North America
    - Europe
    - Asia Pacific
    - Middle East & South Africa
    - Latin America
  • 6.5 SUPPLY CHAIN ANALYSIS
  • 6.6 MARKET ECOSYSTEM
  • 6.7 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR HEALTHCARE DATA MONETIZATION MARKET
    JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.8 CASE STUDY ANALYSIS
    CASE STUDY 1: TO FIND OUT INEFFICIENCIES IN HEALTHCARE CHAIN ON PER PATIENT BASIS
    CASE STUDY 2: LEADING HEALTHCARE REVENUE MANAGEMENT COMPANY CUTS DEVELOPER COSTS BY 50%
    CASE STUDY 3: SAKURA FINETEK EUROPE FUTURE-PROOFS ITS BUSINESS WITH ORACLE CLOUD APPLICATIONS
    CASE STUDY 4: AMERISOURCEBERGEN GAINS FINANCE EFFICIENCIES WITH ORACLE CLOUD EPM
    CASE STUDY 5: SKYGEN CUTS FINANCIAL CLOSE TO ONLY 10 DAYS USING ORACLE CLOUD ERP AND EPM
    CASE STUDY 6: HEALTH FIRST USES AZURE SYNAPSE ANALYTICS TO CREATE A DATA MANAGEMENT SOLUTION, IMPROVING REFRESH SPEEDS BY 75%
    CASE STUDY 7: COMMERCIAL UNDERWRITING
    CASE STUDY 8: PRAGMATIC CLINICAL TRIALS
    CASE STUDY 9: VALIDATING AUDIENCE QUALITY
    CASE STUDY 10: SYNTHETIC CONTROL ARM
  • 6.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 6.11 KEY CONFERENCES & EVENTS, 2023–2024
  • 6.12 AVERAGE SELLING PRICE: DATA MONETIZATION MARKET
  • 6.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    REVENUE SHIFTS AND NEW REVENUE POCKETS FOR HEALTHCARE DATA MONETIZATION SOLUTION PROVIDERS
HEALTHCARE DATA MONETIZATION MARKET, BY TYPE
100
  • 7.1 INTRODUCTION
  • 7.2 DIRECT DATA MONETIZATION
    SOFTWARE
    - Rising adoption of artificial intelligence, machine learning, and blockchain to drive growth
    SERVICES
    - Cloud-based infrastructure, scalability, and cost-effectiveness to improve adoption of direct data monetization services
  • 7.3 INDIRECT DATA MONETIZATION
    SOFTWARE
    - Growing focus on data analytics and insights to favor market growth
    SERVICES
    - Advantages such as interoperability and data integration to boost adoption of indirect data monetization services
HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT TYPE
117
  • 8.1 INTRODUCTION
  • 8.2 ON-PREMISE
    SECURITY CONCERNS AND GREATER CONTROL OVER SYSTEM CONFIGURATION TO DRIVE ADOPTION OF ON-PREMISE SOLUTIONS
  • 8.3 CLOUD
    GROWING NEED TO OPTIMIZE DEPLOYMENT COSTS TO FUEL GROWTH
HEALTHCARE DATA MONETIZATION MARKET, BY END USER
123
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INTEGRATION OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO BOOST MARKET GROWTH
  • 9.3 HEALTHCARE PAYERS
    GROWING ADOPTION OF ADVANCED ANALYTICS TO SHAPE HEALTHCARE DATA MONETIZATION ECOSYSTEM FOR PAYERS
  • 9.4 HEALTHCARE PROVIDERS
    NEED TO OPTIMIZE CLINICAL WORKFLOWS AND IDENTIFY HIGH-RISK POPULATIONS TO BOOST MARKET
  • 9.5 MEDICAL TECHNOLOGY COMPANIES
    INCREASING PENETRATION OF CONNECTED MEDICAL DEVICES AND WEARABLES TO PROPEL MARKET GROWTH
  • 9.6 OTHER END USERS
HEALTHCARE DATA MONETIZATION MARKET, BY REGION
134
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American market during forecast period
    CANADA
    - Increasing collaborations and efforts to promote adoption of healthcare data monetization
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    UK
    - Growing penetration of wearables to fuel market growth
    GERMANY
    - Government initiatives to expedite development of digital healthcare ecosystem to enhance market growth
    FRANCE
    - eHealth 2022 plan to promote use of digital technologies
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Growing geriatric population to increase demand for effective patient management solutions
    CHINA
    - High prevalence of chronic diseases to drive implementation of healthcare data monetization
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    GROWING DIGITAL HEALTH ADOPTION IN REGION TO FAVOR MARKET GROWTH
    LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    GROWING RECOGNITION OF VALUE OF HEALTHCARE DATA IN MEA REGION TO BOOST GROWTH
    MIDDLE EAST & AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
170
  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY MARKET PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
    STARS
    PERVASIVE PLAYERS
    EMERGING LEADERS
    PARTICIPANTS
  • 11.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    RESPONSIVE COMPANIES
    STARTING BLOCKS
    HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE BENCHMARKING
  • 11.7 HEALTHCARE DATA MONETIZATION MARKET: COMPANY FOOTPRINT
  • 11.8 COMPETITIVE SCENARIOS AND TRENDS
    PRODUCT LAUNCHES & ENHANCEMENTS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
190
  • 12.1 KEY PLAYERS
    ORACLE CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    MICROSOFT CORPORATION
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    GOOGLE
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SALESFORCE, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SAS INSTITUTE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    - MnM view
    SAP SE
    - Business overview
    - Products & services offered
    - Recent developments
    TIBCO SOFTWARE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SNOWFLAKE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    QLIKTECH INTERNATIONAL AB
    - Business overview
    - Products & services offered
    - Recent developments
    HEALTHVERITY, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    SISENSE INC.
    - Business overview
    - Products & services offered
    - Recent developments
    ACCENTURE
    - Business overview
    - Products & services offered
    - Recent developments
    AVAILITY, LLC
    - Business overview
    - Products & services offered
    - Recent developments
    DOMO, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    KOMODO HEALTH, INC.
    - Business overview
    - Products & services offered
    - Recent developments
    THOUGHTSPOT INC.
    - Business overview
    - Products & services offered
    - Recent developments
    DATAVANT
    - Business overview
    - Products & services offered
    - Recent developments
    VERATO
    - Business overview
    - Products & services offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    INFOR, INC.
    VIRTUSA
    INFOSYS
    PARTICLE HEALTH, INC.
    INNOVACCER, INC.
    H1
    MEDABLE INC.
APPENDIX
274
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 FACTOR ANALYSIS
  • TABLE 3 ASSUMPTIONS FOR RESEARCH STUDY
  • TABLE 4 LIMITATIONS AND ASSOCIATED RISKS
  • TABLE 5 LARGEST HEALTHCARE DATA BREACHES (2009–MAY 2023)
  • TABLE 6 HEALTHCARE DATA MONETIZATION MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2023
  • TABLE 7 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 9 KEY BUYING CRITERIA, BY END USER (%)
  • TABLE 10 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • TABLE 11 COMMONLY ADOPTED PRICING STRATEGIES IN HEALTHCARE DATA MONETIZATION MARKET
  • TABLE 12 MICROSOFT CORPORATION: PRICING OF AZURE HEALTH DATA SERVICES
  • TABLE 13 MICROSOFT CORPORATION: PRICING OF AZURE API FOR FHIR
  • TABLE 14 MICROSOFT CORPORATION: PRICING OF AZURE DATA SHARE
  • TABLE 15 MICROSOFT CORPORATION: PRICING OF MEDIA SERVICES
  • TABLE 16 SALESFORCE, INC.: PRICING OF HEALTH CLOUD
  • TABLE 17 SALESFORCE, INC.: PRICING OF DATA CLOUD FOR HEALTH
  • TABLE 18 SALESFORCE, INC.: PRICING OF ADDITIONAL SOLUTIONS
  • TABLE 19 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 20 DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 21 DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 23 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 25 DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 27 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 29 DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 31 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 33 INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 34 INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 36 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 38 INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 40 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 42 INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 44 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 46 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT TYPE, 2021–2028 (USD MILLION)
  • TABLE 47 ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 48 NORTH AMERICA: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 49 EUROPE: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: ON-PREMISE HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 51 CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 53 EUROPE: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: CLOUD-BASED HEALTHCARE DATA MONETIZATION SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 55 HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 56 HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 58 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 60 HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 61 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 62 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 64 HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 65 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 66 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 68 HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 69 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 70 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR MEDICAL TECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 72 HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 73 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 74 EUROPE: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 76 HEALTHCARE DATA MONETIZATION MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 77 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 78 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 79 NORTH AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 80 NORTH AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 81 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 82 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 83 US: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 84 US: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 85 US: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 86 US: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 87 US: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 88 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 89 CANADA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 90 CANADA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 91 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 92 CANADA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 93 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 94 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 95 EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 96 EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 97 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 98 EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 99 UK: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 100 UK: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 101 UK: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 102 UK: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 103 UK: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 104 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 105 GERMANY: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 106 GERMANY: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 107 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 108 GERMANY: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 109 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 110 FRANCE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 111 FRANCE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 112 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 113 FRANCE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 114 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 115 REST OF EUROPE: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 116 REST OF EUROPE: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 117 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 118 REST OF EUROPE: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 125 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 126 JAPAN: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 127 JAPAN: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 128 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 129 JAPAN: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 130 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 131 CHINA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 132 CHINA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 133 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 134 CHINA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 135 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 136 REST OF ASIA PACIFIC: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 137 REST OF ASIA PACIFIC: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 138 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 139 REST OF ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 140 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 141 LATIN AMERICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 142 LATIN AMERICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 143 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 144 LATIN AMERICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: DIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: INDIRECT HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2021–2028 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2021–2028 (USD MILLION)
  • TABLE 150 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE DATA MONETIZATION MARKET, JANUARY 2021–MAY 2023
  • TABLE 151 HEALTHCARE DATA MONETIZATION MARKET: DETAILED LIST OF KEY SMES/STARTUPS
  • TABLE 152 HEALTHCARE DATA MONETIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY SMES SMES/STARTUPS
  • TABLE 153 BY TYPE: COMPANY FOOTPRINT
  • TABLE 154 BY END USER: COMPANY FOOTPRINT
  • TABLE 155 BY REGION: COMPANY FOOTPRINT
  • TABLE 156 COMPANY FOOTPRINT
  • TABLE 157 HEALTHCARE DATA MONETIZATION MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, 2021–2023
  • TABLE 158 HEALTHCARE DATA MONETIZATION MARKET: DEALS, 2021–2023
  • TABLE 159 HEALTHCARE DATA MONETIZATION MARKET: OTHER DEVELOPMENTS, 2021–2023
  • TABLE 160 ORACLE CORPORATION: COMPANY OVERVIEW
  • TABLE 161 ORACLE CORPORATION: PRODUCT LAUNCHES
  • TABLE 162 ORACLE CORPORATION: DEALS
  • TABLE 163 ORACLE CORPORATION: OTHER DEVELOPMENTS
  • TABLE 164 MICROSOFT CORPORATION: COMPANY OVERVIEW
  • TABLE 165 MICROSOFT CORPORATION: PRODUCT ENHANCEMENTS
  • TABLE 166 MICROSOFT CORPORATION: DEALS
  • TABLE 167 GOOGLE: COMPANY OVERVIEW
  • TABLE 168 GOOGLE: PRODUCT LAUNCHES
  • TABLE 169 GOOGLE: DEALS
  • TABLE 170 GOOGLE: OTHER DEVELOPMENTS
  • TABLE 171 SALESFORCE, INC.: COMPANY OVERVIEW
  • TABLE 172 SALESFORCE, INC.: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 173 SALESFORCE, INC: DEALS
  • TABLE 174 SALESFORCE, INC.: OTHER DEVELOPMENTS
  • TABLE 175 SAS INSTITUTE INC.: COMPANY OVERVIEW
  • TABLE 176 SAS INSTITUTE INC.: PRODUCT LAUNCHES
  • TABLE 177 SAS INSTITUTE INC: DEALS
  • TABLE 178 SAS INSTITUTE INC.: OTHER DEVELOPMENTS
  • TABLE 179 SAP SE: COMPANY OVERVIEW
  • TABLE 180 SAP SE: PRODUCT LAUNCHES
  • TABLE 181 SAP SE: DEALS
  • TABLE 182 SAP SE: OTHER DEVELOPMENTS
  • TABLE 183 TIBCO SOFTWARE INC.: COMPANY OVERVIEW
  • TABLE 184 TIBCO SOFTWARE INC.: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 185 TIBCO SOFTWARE INC.: DEALS
  • TABLE 186 SNOWFLAKE INC.: COMPANY OVERVIEW
  • TABLE 187 SNOWFLAKE INC.: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 188 SNOWFLAKE INC.: DEALS
  • TABLE 189 QLIKTECH INTERNATIONAL AB: COMPANY OVERVIEW
  • TABLE 190 QLIKTECH INTERNATIONAL AB: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 191 QLIKTECH INTERNATIONAL AB: DEALS
  • TABLE 192 HEALTHVERITY, INC.: COMPANY OVERVIEW
  • TABLE 193 HEALTHVERITY, INC.: PRODUCT LAUNCHES
  • TABLE 194 HEALTHVERITY, INC.: DEALS
  • TABLE 195 SISENSE INC.: COMPANY OVERVIEW
  • TABLE 196 SISENSE INC.: DEALS
  • TABLE 197 ACCENTURE: COMPANY OVERVIEW
  • TABLE 198 ACCENTURE: DEALS
  • TABLE 199 AVAILITY, LLC: COMPANY OVERVIEW
  • TABLE 200 AVAILITY, LLC: PRODUCT LAUNCHES
  • TABLE 201 AVAILITY, LLC: DEALS
  • TABLE 202 DOMO, INC.: COMPANY OVERVIEW
  • TABLE 203 DOMO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 204 KOMODO HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 205 KOMODO HEALTH, INC.: PRODUCT LAUNCHES
  • TABLE 206 KOMODO HEALTH, INC.: DEALS
  • TABLE 207 THOUGHTSPOT INC.: COMPANY OVERVIEW
  • TABLE 208 THOUGHTSPOT INC.: PRODUCT LAUNCHES
  • TABLE 209 THOUGHTSPOT INC.: DEALS
  • TABLE 210 THOUGHTSPOT INC.: OTHER DEVELOPMENTS
  • TABLE 211 DATAVANT: COMPANY OVERVIEW
  • TABLE 212 DATAVANT: PRODUCT LAUNCHES & ENHANCEMENTS
  • TABLE 213 DATAVANT: DEALS
  • TABLE 214 VERATO: COMPANY OVERVIEW
  • TABLE 215 VERATO: PRODUCT LAUNCHES
  • TABLE 216 VERATO: DEALS
  • TABLE 217 VERATO: OTHER DEVELOPMENTS
LIST OF FIGURES
 
  • FIGURE 1 HEALTHCARE DATA MONETIZATION MARKET: MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 RESEARCH APPROACH
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 APPROACH FOR ASSESSING SUPPLY OF HEALTHCARE DATA MONETIZATION SOLUTIONS
  • FIGURE 7 REVENUES GENERATED BY COMPANIES FROM SALES OF HEALTHCARE DATA MONETIZATION SOLUTIONS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 9 BOTTOM-UP APPROACH
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 ESTIMATION OF HEALTHCARE DATA MONETIZATION MARKET SIZE BASED ON PARENT MARKET
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 HEALTHCARE DATA MONETIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 14 HEALTHCARE DATA MONETIZATION MARKET, BY DEPLOYMENT, 2023 VS. 2028 (USD MILLION)
  • FIGURE 15 HEALTHCARE DATA MONETIZATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 HEALTHCARE DATA MONETIZATION MARKET: REGIONAL SNAPSHOT
  • FIGURE 17 EXPONENTIALLY INCREASING DATA VOLUME AND GENERATION OF LARGE AND COMPLEX HEALTHCARE DATASETS TO DRIVE MARKET
  • FIGURE 18 NORTH AMERICA TO DOMINATE HEALTHCARE DATA MONETIZATION MARKET DURING FORECAST PERIOD
  • FIGURE 19 JAPAN TO REGISTER HIGHEST REVENUE GROWTH FROM 2023 TO 2028
  • FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US DOMINATED MARKET IN NORTH AMERICA IN 2022
  • FIGURE 21 DIRECT DATA MONETIZATION SEGMENT TO HOLD LARGER MARKET SHARE IN 2028
  • FIGURE 22 ON-PREMISE DEPLOYMENT SEGMENT TO DOMINATE MARKET IN 2028
  • FIGURE 23 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2028
  • FIGURE 24 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: HEALTHCARE DATA MONETIZATION MARKET
  • FIGURE 25 US: ADOPTION OF ELECTRONIC HEALTH RECORDS, BY HOSPITAL SERVICE TYPE (2021)
  • FIGURE 26 US HEALTHCARE SPENDING, 2012–2030 (USD BILLION)
  • FIGURE 27 US: NUMBER OF DATA BREACHES (2009–MAY 2023)
  • FIGURE 28 DIRECT VS. INDIRECT DATA MONETIZATION
  • FIGURE 29 HEALTHCARE DATA MONETIZATION MARKET: SUPPLY CHAIN
  • FIGURE 30 HEALTHCARE DATA MONETIZATION MARKET: MARKET ECOSYSTEM
  • FIGURE 31 PATENT PUBLICATION TRENDS, JANUARY 2012–APRIL 2023
  • FIGURE 32 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE DATA MONETIZATION SOLUTIONS, JANUARY 2012–APRIL 2023
  • FIGURE 33 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR HEALTHCARE DATA MONETIZATION PATENTS, JANUARY 2012–APRIL 2023
  • FIGURE 34 HEALTHCARE DATA MONETIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 36 KEY BUYING CRITERIA, BY END USER
  • FIGURE 37 PRICING ANALYSIS: DATA MONETIZATION MARKET
  • FIGURE 38 REVENUE SHIFT FOR HEALTHCARE DATA MONETIZATION SOLUTION PROVIDERS
  • FIGURE 39 DIRECT DATA MONETIZATION SEGMENT HELD LARGEST MARKET SHARE IN 2022
  • FIGURE 40 DIRECT DATA MONETIZATION SOFTWARE SEGMENT DOMINATED MARKET IN 2022
  • FIGURE 41 INDIRECT DATA MONETIZATION SOFTWARE SEGMENT DOMINATED MARKET IN 2022
  • FIGURE 42 ON-PREMISE DATA MONETIZATION SOLUTIONS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 43 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • FIGURE 44 JAPAN TO EMERGE AS NEW HOTSPOT DURING FORECAST PERIOD
  • FIGURE 45 NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE DATA MONETIZATION MARKET IN 2022
  • FIGURE 46 NORTH AMERICA: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: HEALTHCARE DATA MONETIZATION MARKET SNAPSHOT
  • FIGURE 48 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS, 2022
  • FIGURE 49 HEALTHCARE DATA MONETIZATION MARKET: MARKET SHARE ANALYSIS, 2022
  • FIGURE 50 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
  • FIGURE 51 HEALTHCARE DATA MONETIZATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
  • FIGURE 52 ORACLE CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 53 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 54 GOOGLE: COMPANY SNAPSHOT (2022)
  • FIGURE 55 SALESFORCE, INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 56 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 57 SAP SE: COMPANY SNAPSHOT (2022)
  • FIGURE 58 SNOWFLAKE INC.: COMPANY SNAPSHOT (2022)
  • FIGURE 59 ACCENTURE: COMPANY SNAPSHOT (2022)
  • FIGURE 60 DOMO, INC.: COMPANY SNAPSHOT (2022)

The study involved major activities in estimating the current size of the global healthcare data monetization market. Exhaustive secondary research was done to collect information on the peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of the segments and subsegments.

Secondary Research

This research study involved the use of widespread secondary sources; directories; databases, such as D&B, Bloomberg Business, and Factiva; white papers; government sources; corporate filings (such as annual reports, investor presentations, and financial statements); and trade, business, and professional associations; and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the healthcare data monetization market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the healthcare data monetization market. The primary sources from the demand side include key executives from pharmaceutical & biotechnology companies, research centers, academic institutes, & government organizations, hospitals, healthcare providers, healthcare payers, medical technology companies, contract research organizations, non-profit organizations (NPOs), agri-genomics organizations, and direct-to-consumer companies. After the complete market engineering process (which includes calculations for the market statistics, market breakdown, market size estimation, market forecasts, and data triangulation), extensive primary research has been conducted to gather information and verify and validate the critical numbers obtained.

Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, deployment, end user, and region.

A breakdown of the primary respondents is provided below:

 

Healthcare Data Monetization Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down (segmental analysis of major segments) and bottom-up approaches (assessment of utilization/adoption/penetration trends, by type, deployment, end user, and region) were used to estimate and validate the total size of the healthcare data monetization market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research, and their market share in the respective regions have been determined through both primary and secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Healthcare data monetization Market Size: Top-Down Approach

Healthcare Data Monetization Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market has been split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, the data triangulation and market breakdown processes have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand- and supply sides. Along with this, the market has been validated using both the top-down and bottom-up approaches.

Market definition

Data Monetization refers to the process of using data to obtain quantifiable economic benefit. Data monetization tools enable end users to manage and control secure access to data assets and analyze it for generating new revenue streams. In the monetization process, data assets such as customer data, product data, and financial data generated through business transactions are used for generating value in organizations. Data monetization is a way to generate revenue from available data sources by discovering, capturing, storing, and analyzing data.

Internal or indirect methods include using data to make measurable business performance improvements and inform decisions. External or direct methods include data sharing to gain beneficial terms or conditions from business partners, information bartering, selling data outright (via a data broker or independently), or offering information products and services (for example, including information as a value-added component of an existing offering).

Direct monetization in healthcare involves selling healthcare data directly to customers, such as other healthcare organizations, research institutions, or individuals, for a fee. This data can be raw or processed, and may include electronic health records, medical claims data, clinical trial data, and patient-generated data. Indirect monetization in healthcare involves using healthcare data to improve existing products or services, or to create new ones that generate revenue. In this approach, healthcare data is used as a resource to support business objectives rather than being sold directly to customers.

Key Stakeholders

  • Healthcare Data Monetization Solution Providers
  • Platform Providers
  • Technology Providers
  • AI System Providers
  • Raw Data Providers
  • Data Buyers
  • Data Sellers
  • Healthcare Providers
  • Healthcare Payers
  • Pharmaceutical & Biotechnology Companies
  • Medical Technology Companies
  • Physician Groups and Organizations
  • Universities and Research Organizations
  • Forums, Alliances, and Associations
  • Academic Research Institutes
  • Healthcare Institutions
  • Distributors
  • Venture Capitalists
  • Government Organizations
  • Institutional Investors and Investment Banks
  • Investors/Shareholders
  • Consulting Companies in the Data Monetization Sector
  • Raw Materials and Component Manufacturers

Objectives of the Study

  • To define, describe, and forecast the healthcare data monetization market size, by type, deployment, end user, and region, in terms of value
  • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall healthcare data monetization market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the healthcare data monetization market in four main regions (along with their respective key countries), namely, North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America, in terms of value
  • To provide key industry insights such as supply chain analysis, regulatory analysis, patent analysis, and recession impact analysis
  • To profile the key players in the healthcare data monetization market and comprehensively analyze their core competencies2
  • To track and analyze competitive developments such as product launches and enhancemnets, and partnerships, acquisitions, investments, sales contracts, agreements, collaborations, alliances, expansions, and R&D activities of the leading players in the healthcare data monetization market
  • To benchmark players within the healthcare data monetization market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for this report:

Product Analysis

  • Product Matrix, Which Gives A Detailed Comparison Of The Product Portfolio Of Each Company

Geographic Analysis

  • Further Breakdown Of Latin American The Healthcare Data Monetization Market Into Brazil, Mexico, And The Rest Of Latin America.
  • Further Breakdown Of The Middle East & Africa The Healthcare Data Monetization Market Into The Uae, Saudi Arabia, South Africa, And The Rest Of Mea Countries

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
HIT 8682
Published ON
Jun, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Data Monetization Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Hold On!

Want to explore hidden markets that can drive new revenue in Healthcare Data Monetization Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback